http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020079299-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 |
| filingDate | 2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6df4cd82a8dfd0346ace20667e411748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5af774114d86b38f54a0d01388bdb3b6 |
| publicationDate | 2020-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2020079299-A |
| titleOfInvention | Proteasome inhibitor |
| abstract | PROBLEM TO BE SOLVED: To provide a novel compound useful as a proteasome inhibitor. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. The compound of the present invention is a compound of general formula (I) or a pharmaceutically acceptable salt or boronic anhydride thereof, wherein Z 1 and Z 2 are each independently hydroxy, alkoxy, aryloxy. , Or aralkoxy, or Z 1 and Z 2 together form a moiety derived from the boronic acid complexing agent. [Selection diagram] None |
| priorityDate | 2020-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 280.